These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29697435)

  • 21. Healing of recurrent herpes simplex corneal epithelial lesions treated with topical acyclovir A non-contact photomicrographic in vivo study in the human cornea.
    Tabery HM
    Acta Ophthalmol Scand; 2001 Jun; 79(3):256-61. PubMed ID: 11401634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of the herpetic eye disease studies on the management of herpes simplex virus ocular infections.
    Sudesh S; Laibson PR
    Curr Opin Ophthalmol; 1999 Aug; 10(4):230-3. PubMed ID: 10621528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Battle with herpes for 37 years].
    Shimomura Y
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):145-66; discussion 167. PubMed ID: 25854108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New onset of herpes simplex virus epithelial keratitis after penetrating keratoplasty.
    Rezende RA; Uchoa UB; Raber IM; Rapuano CJ; Laibson PR; Cohen EJ
    Am J Ophthalmol; 2004 Mar; 137(3):415-9. PubMed ID: 15013862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis.
    Colin J; Hoh HB; Easty DL; Herbort CP; Resnikoff S; Rigal D; Romdane K
    Cornea; 1997 Jul; 16(4):393-9. PubMed ID: 9220235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. The Herpetic Eye Disease Study Group.
    Arch Ophthalmol; 1996 Sep; 114(9):1065-72. PubMed ID: 8790090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates.
    Yao YF; Inoue Y; Kase T; Uchihori Y; Mori Y; Ohashi Y
    Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S126-32. PubMed ID: 8871163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of oral valaciclovir on herpetic keratitis.
    Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
    Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of four antiviral agents in the treatment of uncomplicated herpetic keratitis.
    Panda A; Das GK; Khokhar S; Rao V
    Can J Ophthalmol; 1995 Aug; 30(5):256-8. PubMed ID: 8529160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The treatment of herpes simplex virus epithelial keratitis.
    Wilhelmus KR
    Trans Am Ophthalmol Soc; 2000; 98():505-32. PubMed ID: 11190039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study.
    Heiligenhaus A; Steuhl KP
    Graefes Arch Clin Exp Ophthalmol; 1999 May; 237(5):435-8. PubMed ID: 10333113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpetic epithelial keratitis after intravitreal injection of bevacizumab (avastin).
    Khalili MR; Mehdizadeh M; Mehryar M
    Cornea; 2009 Apr; 28(3):360-1. PubMed ID: 19387245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Herpetic eye disease study: lessons learned.
    Kalezic T; Mazen M; Kuklinski E; Asbell P
    Curr Opin Ophthalmol; 2018 Jul; 29(4):340-346. PubMed ID: 29846207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis.
    Barron BA; Gee L; Hauck WW; Kurinij N; Dawson CR; Jones DB; Wilhelmus KR; Kaufman HE; Sugar J; Hyndiuk RA
    Ophthalmology; 1994 Dec; 101(12):1871-82. PubMed ID: 7997323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.
    Burrel S; Boutolleau D; Azar G; Doan S; Deback C; Cochereau I; Agut H; Gabison EE
    J Clin Virol; 2013 Sep; 58(1):321-4. PubMed ID: 23731845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations.
    Majumdar S; Nashed YE; Patel K; Jain R; Itahashi M; Neumann DM; Hill JM; Mitra AK
    J Ocul Pharmacol Ther; 2005 Dec; 21(6):463-74. PubMed ID: 16386088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of oral ganciclovir for prophylaxis and treatment of recurrent herpes simplex keratitis.
    Wang X; Wang L; Wu N; Ma X; Xu J
    Chin Med J (Engl); 2015 Jan; 128(1):46-50. PubMed ID: 25563312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
    Duan R; de Vries RD; Osterhaus AD; Remeijer L; Verjans GM
    J Infect Dis; 2008 Sep; 198(5):659-63. PubMed ID: 18627246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of herpetic keratitis with acyclovir: benefits and problems.
    Ohashi Y
    Ophthalmologica; 1997; 211 Suppl 1():29-32. PubMed ID: 9065935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of Neonatal Herpes Simplex Infection: A Rare Case of Blepharoconjunctivitis and Concurrent Epithelial and Stromal Keratitis.
    Matos RJC; Pires JMS; Cortesão D
    Ocul Immunol Inflamm; 2018; 26(4):625-627. PubMed ID: 27849421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.